Cardinal Health, Inc. $CAH Stock: Counterpoint Mutual Funds LLC Increases Position

Key Points

• Counterpoint Mutual Funds increased its Cardinal Health stake by 32.9% in the third quarter, acquiring 10,528 additional shares for a total holding valued at approximately $9.45 million. Institutional investors and hedge funds collectively own 87.17% of the company.
• Cardinal Health reported quarterly EPS of $2.91, beating consensus estimates of $2.42, while revenue rose 5.8% year over year to $63.67 billion. The company guided to fiscal 2027 EPS of $12.40–$12.60.
• Analysts maintain a favorable outlook, with a consensus “Moderate Buy” rating and an average price target of $267.50 versus the stock’s reported $253.86 price. Cardinal Health also pays an annualized dividend of $2.06 per share, yielding about 0.8%.

Counterpoint Mutual Funds LLC lifted its stake in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 32.9% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 42,485 shares of the company's stock after purchasing an additional 10,528 shares during the period. Cardinal Health makes up 0.8% of Counterpoint Mutual Funds LLC's investment portfolio, making the stock its 29th largest holding. Counterpoint Mutual Funds LLC's holdings in Cardinal Health were worth $9,453,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently modified their holdings of CAH. BlackRock Inc. acquired a new position in shares of Cardinal Health in the second quarter valued at approximately $6,293,115,000. Wellington Management Group LLP boosted its stake in shares of Cardinal Health by 247.5% in the second quarter. Wellington Management Group LLP now owns 14,860,271 shares of the company's stock valued at $3,530,206,000 after purchasing an additional 10,584,119 shares during the period. Bank of America Corp DE acquired a new position in shares of Cardinal Health in the second quarter worth about $689,066,000. Legal & General Group Plc purchased a new position in shares of Cardinal Health during the 2nd quarter valued at approximately $438,870,000. Finally, Pacer Advisors Inc. grew its holdings in Cardinal Health by 14.7% during the 1st quarter. Pacer Advisors Inc. now owns 1,565,131 shares of the company's stock worth $330,728,000 after acquiring an additional 200,021 shares in the last quarter. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Trading Up 0.1%

Shares of NYSE CAH opened at $253.86 on Friday. Cardinal Health, Inc. has a 12-month low of $152.46 and a 12-month high of $258.30. The company has a market cap of $58.78 billion, a price-to-earnings ratio of 35.11, a price-to-earnings-growth ratio of 1.53 and a beta of 0.50. The stock's 50 day simple moving average is $234.54 and its 200 day simple moving average is $222.22.

Cardinal Health (NYSE:CAH - Get Free Report) last posted its earnings results on Tuesday, August 11th. The company reported $2.91 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.42 by $0.49. The firm had revenue of $63.67 billion during the quarter, compared to analyst estimates of $65.15 billion. Cardinal Health had a net margin of 0.67% and a negative return on equity of 98.53%. Cardinal Health's revenue was up 5.8% on a year-over-year basis. During the same period in the previous year, the business posted $2.08 EPS. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. As a group, equities analysts forecast that Cardinal Health, Inc. will post 12.55 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, October 15th. Shareholders of record on Thursday, October 1st were paid a dividend of $0.5158 per share. The ex-dividend date of this dividend was Thursday, October 1st. This represents a $2.06 annualized dividend and a yield of 0.8%. Cardinal Health's payout ratio is presently 28.49%.

Analysts Set New Price Targets

Several brokerages have issued reports on CAH. TD Cowen upped their price objective on Cardinal Health from $275.00 to $280.00 and gave the company a "buy" rating in a research note on Thursday, August 13th. Royal Bank Of Canada began coverage on Cardinal Health in a research report on Wednesday, August 19th. They issued an "outperform" rating and a $276.00 target price for the company. Robert W. Baird boosted their price target on Cardinal Health from $251.00 to $274.00 and gave the company an "outperform" rating in a report on Wednesday, August 12th. Evercore restated an "outperform" rating and set a $270.00 price objective on shares of Cardinal Health in a research note on Wednesday, August 12th. Finally, Weiss Ratings upgraded Cardinal Health from a "buy (b)" rating to a "buy (b+)" rating in a research note on Thursday, October 8th. Sixteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $267.50.

Insider Activity

In other Cardinal Health news, insider Michelle Greene sold 11,650 shares of the business's stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $235.72, for a total transaction of $2,746,138.00. Following the completion of the transaction, the insider owned 10,330 shares in the company, valued at approximately $2,434,987.60. The trade was a 53.00% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Jessica Mayer sold 29,436 shares of the stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $236.19, for a total value of $6,952,488.84. Following the completion of the transaction, the insider directly owned 33,076 shares of the company's stock, valued at approximately $7,812,220.44. The trade was a 47.09% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 210,271 shares of company stock worth $49,626,657 over the last ninety days. 0.12% of the stock is currently owned by company insiders.

Cardinal Health Profile

Cardinal Health, Inc is a healthcare services and products company that supports pharmacies, hospitals, ambulatory surgery centers, physician offices and other healthcare providers. Its operations are primarily organized into Pharmaceutical and Medical segments.

The Pharmaceutical segment distributes branded, generic, specialty and over-the-counter medicines, as well as consumer health products. It also provides services related to specialty pharmaceuticals, pharmaceutical sourcing, nuclear and precision health products, and data and analytics for pharmaceutical manufacturers and healthcare organizations.

The Medical segment distributes medical and surgical products, including gloves, apparel, incontinence supplies, laboratory products and other essential items.

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.